Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Non Operating Investment Income (2018 - 2025)

Inspire Medical Systems' Non Operating Investment Income history spans 8 years, with the latest figure at -$47000.0 for Q4 2025.

  • For Q4 2025, Non Operating Investment Income rose 95.36% year-over-year to -$47000.0; the TTM value through Dec 2025 reached $224000.0, up 212.56%, while the annual FY2025 figure was $224000.0, 212.56% up from the prior year.
  • Non Operating Investment Income for Q4 2025 was -$47000.0 at Inspire Medical Systems, down from $302000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $1.6 million in Q3 2024 and bottomed at -$1.0 million in Q4 2024.
  • The 5-year median for Non Operating Investment Income is -$17000.0 (2021), against an average of $28350.0.
  • The largest YoY upside for Non Operating Investment Income was 1175.41% in 2024 against a maximum downside of 19900.0% in 2024.
  • A 5-year view of Non Operating Investment Income shows it stood at -$46000.0 in 2021, then soared by 278.26% to $82000.0 in 2022, then soared by 646.34% to $612000.0 in 2023, then tumbled by 265.52% to -$1.0 million in 2024, then skyrocketed by 95.36% to -$47000.0 in 2025.
  • Per Business Quant, the three most recent readings for INSP's Non Operating Investment Income are -$47000.0 (Q4 2025), $302000.0 (Q3 2025), and -$22000.0 (Q2 2025).